Objective: We hypothesized that deficiency in 25-hydroxyvitamin D at critical care initiation would be associated with all-cause mortalities.
V itamin D is a fat-soluble vitamin that is mainly produced in the skin by ultraviolet-B light conversion of 7-dehydrocholesterol, or ingested in the diet from fatty fish, cod-liver oil, eggs, fortified milk products, or dietary supplements. Active vitamin D increases the intestinal absorption of calcium, and decreases re-nal calcium and phosphate excretion (1) . Vitamin D deficiency has been implicated in chronic diseases, such as cardiovascular disease, hypertension, diabetes, cancer, autoimmune disorders, and increased overall mortality (2) (3) (4) (5) , but its role in morbidity and mortality of the critically ill is not well described.
Data on the exact prevalence of vitamin D deficiency in the critically ill is limited. Seventeen percent of critically ill patients in a small prospective study had levels of vitamin D below assay limits (6) . Very low serum concentrations of 25hydroxyvitamin D (25[OH]D) and of 1,25 dihydroxyvitamin D3 are documented in critically ill patients who have prolonged stays, likely related to decreased ultraviolet-B sunlight exposure and immobility (7) (8) (9) (10) (11) .
In the outpatient population, serum 25(OH)D is demonstrated to be stable 3 yrs between blood draws following adjustments for age, race, and season (12) . Using this observation, our group previously studied 2,399 critically ill patients, demonstrating that 25(OH)D Ͻ30 ng/mL up to 365 days before hospital admission was a strong predictor of all-cause mortality (13) .
The half-life of 25(OH)D is 15 days (14) . It is not known if vitamin D insufficiency or deficiency at the time of critical care affects survival or if critical illness alters vitamin D levels. Vitamin D has broad effects on immunity, inflammation, glucose and calcium metabolism, and endothelial and mucosal functions. The observed effects of vitamin D may be related to the presence of vitamin D receptors in multiple cell types and organs and the production of 1,25 dihydroxyvitamin D3 in the kidney and in extrarenal organs (15) .
To explore the role of vitamin D deficiency at the time of critical care initiation in the outcome of critically ill patients, we performed an 11-yr, two-center observational study of patients among whom 25(OH)D was measured within 7 days before or 7 days after critical care initiation. The aim of this study is to determine the relationship between 25(OH)D deficiency at critical care initiation and subsequent mortality. Subanalyses will determine the effect of albu-min, socioeconomic status (SES), and race on the relationship between 25(OH)D and mortality in our cohort.
MATERIALS AND METHODS

Source Population
We extracted administrative and laboratory data from individuals admitted to two academic teaching hospitals in Boston, MA. Brigham and Women's Hospital is a 777-bed teaching hospital with 100 critical care beds. Massachusetts General Hospital is a 902-bed teaching hospital with 109 critical care beds. The two hospitals provide primary as well as tertiary care to an ethnically and socioeconomically diverse population within eastern Massachusetts and the surrounding region.
Data Sources
Data on all patients admitted to Brigham and Women's Hospital or Massachusetts General Hospital between November 2, 1997 and April 1, 2009 were obtained through a computerized registry which serves as a central clinical data warehouse for all inpatients and outpatients seen at these hospitals. The administrative database used in this cohort study is called the Research Patient Data Registry, a registry maintained by the administrative body that oversees operations at Brigham and Women's Hospital and Massachusetts General Hospital (16) . The database contains information on demographics, medications, laboratory values, microbiology data, procedures, and the records of inpatient and outpatients. This administrative database has been used for other clinical studies (13, (17) (18) (19) . Approval for the study was granted by the Institutional Review Board of Brigham and Women's Hospital. The Institutional Review Board waived the need for informed consent.
The following data were retrieved: demographics; vital status for up to 11 yrs following critical care initiation; 25(OH)D measured between 7 days prior and 7 days after critical care initiation; year and season 25(OH)D was measured; microbiology data; latitude of patient address; hospital admission and discharge date; diagnosis-related group assigned at discharge; International Classification of Diseases, ninth Revision, Clinical Modification (ICD-9CM) codes; and Current Procedural Terminology (CPT) codes for in-hospital procedures.
Study Population
During the 11-yr period of study, there were 56,604 unique patients, age Ն18 yrs, who were assigned the CPT code 99291 (critical care, first 30 -74 mins). Of these, 2,212 patients with multiple admissions to the hos-pital involving critical care (CPT code 99291 assignment) were identified and excluded; 205 foreign patients without Social Security Numbers were identified and excluded, since vital status in this study was determined by the Social Security Administration Master Death File; and 2,372 patients assigned CPT code 99291 who received care only in the emergency room, were not admitted, and were not assigned a diagnosis-related group were excluded. The Total Critical Care population consisted of 51,815 patients. This Total Critical Care population has been previously described by our group (13) .
A total of 1,327 patients in the Total Critical Care population had blood for 25(OH)D measurement drawn within 7 days before or 7 days after the first day of CPT code 99291 assignment. Eighty-five of the 1,327 patients also had 25(OH)D levels measured up to a year before the hospital admission related to critical care initiation. These 85 patients were identified but not excluded. Two of the 1,327 patients who received high-dose vitamin D supplementation during the hospitalization following the 25(OH)D level draw date were identified and excluded. The study cohort constituted 1,325 patients. This 1,325-patient study cohort did not share any patients with our prior vitamin D study (13) .
Exposure of Interest and Comorbidities
The exposure of interest was 25(OH)D measured in inpatients once during the time range from 7 days before critical care initiation to 7 days after critical care initiation. 25(OH)D was categorized a priori as deficiency (25(OH)D Յ15 ng/mL), insufficiency (25(OH)D 16 -29 ng/mL), and sufficiency (25(OH)D Ն30 ng/mL) (12) .
We utilized the Deyo-Charlson index to assess the burden of chronic illness (20) . The Deyo-Charlson index consists of 17 comorbidities, which are weighted and summed to produce a score each, with an associated weight based on the adjusted risk of 1-yr mortality. This score ranges from 0 to 33, with higher scores indicating a higher burden. The score does not measure type or severity of acute illness (20 -21) . We employed the ICD-9 coding algorithms developed by Quan et al (22) to derive a comorbidity score for each patient. The validity of the algorithms by Quan et al for ICD-9 coding from administrative data have been reported (22) . For the Deyo-Charlson index, ICD-9 codes were obtained before and during hospitalization. Due to scant representation, Deyo-Charlson index scores Ն6 were combined.
We used the 1990 decennial U.S. Census to obtain the percentage of residents living in poverty per census tract (23) , and merged these data with our dataset following geocoding. The percentage of the population living below the federal poverty level has been used previously to describe social inequities in health (24 -26) . Neighborhood poverty was defined by residence in a census tract with at least 20% of persons below the federal poverty level according to the 1990 decennial U.S. Census (24, (27) (28) (29) (30) (31) . In our data, the census tract level corresponded to a small neighborhood with an average of 1,512 (SD 800) residents. Census tracts are common to area-based socioeconomic studies of neighborhood effects on health (32) (33) (34) , and provide more precise estimates than ZIP or post codes (24, 35) . In this study, neighborhood poverty rate was stratified a priori into Ͻ20% and Ն20% categories based on previous literature (36 -38) .
Sepsis was adapted from Martin et al (36) and defined by the presence of any of the following ICD-9-CM codes during hospitalization: 038.0 -038.9, 790.7, 117.9, 112.5, 112.81, 995.92, and 785.52. Acute kidney injury was defined as ICD-9-CM 584.5, 584.6, 584.7, 584.8, or 584.9 seven days before and 3 days after critical care initiation (19) . Procedures recorded included coronary artery bypass graft surgery performed on the day prior to or after critical care initiation (CPT codes 33510 to 33536). Number of organs with failure was adapted from Martin et al (39) and defined by a combination of ICD-9-CM and CPT codes relating to acute organ dysfunction assigned from 3 days before critical care initiation to 30 days after critical care initiation, as outlined in the supplemental data (see Supplemental Digital Content 1, http://links.lww.com/CCM/A311). Patient type is defined as medical or surgical and incorporates the diagnostic-related grouping methodology, devised by the Centers for Medicare and Medicaid Services (40) . Trauma status also incorporates the diagnostic-related grouping methodology. Laboratory data were obtained closest to the first hour of the first day of CPT code 99,291 assignment.
Assessment of Mortality
Information on vital status for the study cohort was obtained from the Social Security Administration Death Master File. Data from the Social Security Administration Death Master File has a reported sensitivity for mortality up to 92.1%, with a specificity of 99.9%, in comparison to Ͼ95% with the National Death Index as the gold standard (41) (42) (43) (44) . The administrative database from which our study cohort was derived is updated monthly using the Social Security Administration Death Master File, which itself is updated weekly (43) . Utilization of the Death Master File allows for long-term follow-up of patients following hospital discharge. The censoring date was April 2, 2010.
End Points
The primary end point was 30-day mortality following critical care initiation. Prespecified secondary end points included 90-day, 365-day, and in-hospital mortality.
Statistical Analysis
Categorical covariates were described by frequency distribution, and compared across vitamin D groups using contingency tables and chi-square testing. Continuous covariates were examined graphically (e.g., histogram, box plot) and in terms of summary statistics (mean, SD, median, interquartile range), and compared across exposure groups using oneway analysis of variance. The outcomes considered were death by days 30, 90, and 365 postcritical care initiation and in-hospital mortality.
Unadjusted associations between vitamin D groups and outcomes were estimated by contingency tables, chi-square testing, and by bivariable logistic regression analysis. Adjusted odds ratios (ORs) were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both vitamin D levels and mortality. For the primary model (30-day mortality), specification of each continuous covariate (as a linear vs. categorical term) was adjudicated by the empirical association with the primary outcome using Akaike's Information Criterion; overall model fit was assessed using the Hosmer-Lemeshow test. Models for secondary analyses (90-day, 365-day, and inhospital mortality) were specified identically to the primary model to bear greatest analogy. For the time to mortality, we estimated the survival curves according to group with the use of the Kaplan-Meier method (45) and compared the results by means of the log-rank test.
To minimize tertiary referral patterns, we conducted a sensitivity analysis considering in-hospital, 30-day, 90-day, and 365-day mortality in patients who lived within 50 miles of the hospital where they received critical care. Analyses were analogous to the above. Additionally, sensitivity analyses were performed for patients with regard to race (white relative to nonwhite, white relative to black, and also white relative to Hispanic patients). Hypothesizing that neighborhood poverty rate might bear differential association to survival among vitamin D-deficient patients, we conducted a sensitivity analysis considering 30-day mortality in patients with a high neighborhood poverty rate. In a subset of patients with albumin measured at critical care initiation, we conducted a sensitivity analysis of hypoalbuminemia. We assessed possible effect modification of sepsis on the risk of mortality and tested the significance of the interaction using the like-lihood-ratio test. All p values presented are two-tailed; values below .05 were considered nominally significant. All analyses were performed using STATA 10.0MP (College Station, TX). Table 1 shows demographic characteristics of the study population. The majority of patients were male (52.1%), white (79.3%), and had medical-related diagnosis-related groups (53.8%). The mean age at critical care initiation was 63.0 (SD 17.2) yrs. The mean latitude was 42.2 (SD 1.5) degrees North. The mean 25(OH)D was 18.2 (SD 13.7) ng/mL. In the cohort, 668 (50.4%) were vitamin D deficient, 472 (35.6%) insufficient, and 185 (14.0%) sufficient. The majority of vitamin D measurements occurred on the day of or on the days after critical care initiation (Ͻ3 to 7 days prior, 7.8%; Ͻ0 to 3 days prior, 9.8%; Ն0 days to 3 days after, 41.5%; Ն3 to 7 days after, 40.9%). In the 85 patients with previous 25(OH)D levels measured within the prior year and at the time of critical care initiation, 25(OH)D declined in 59 patients, with a mean decrease in 25(OH)D of 12.5 (SD 10.0) ng/ mL, whereas in 26 patients, the 25(OH)D increased by a mean of 9.94 (SD 8.15) ng/mL.
RESULTS
Based on diagnosis-related group criteria, no trauma patients were identified. Based on ICD-9-CM code criteria, 364 patients were identified with sepsis, and 410 patients had acute kidney injury. In the study cohort, procedures included coronary artery bypass graft surgery in 44. Due to scant representation, coronary artery bypass graft surgery was not further analyzed in the cohort.
The study cohort differs from the total critical care population in the period studied. In general, the study cohort was an older group with higher comorbidity (Deyo-Charlson Index), more women, more sepsis, higher number of organs with failure, fewer surgical patients, fewer coronary artery bypass graft, and higher mortality than the total critical care population (Table 1) . Patient characteristics of the study cohort were stratified according to 25(OH)D levels ( Table 3 ). Factors that significantly differed between stratified groups included age, race, and sepsis. Factors that did not significantly differ between stratified groups included gender, Deyo-Charlson index, season of 25(OH)D draw, creatinine at critical care initiation date, and patient type. We did not adjust for the number of organs with failure variable in the primary outcome due to overlap of ICD-9 codes with the Deyo-Charlson index.
Primary Outcome
25(OH)D was a strong predictor of allcause mortality with a significant risk gradient across 25(OH)D groups ( Table  4 ). The risk of mortality 30 days following critical care initiation in patients with 25(OH)D values in the deficient group was 1.9-fold that of those with vitamin D sufficiency. 25(OH)D in the cohort remained a significant predictor of risk of mortality following adjustment for age, sex, race, Deyo-Charlson index, season, type (surgical vs. medical), and sepsis. The adjusted risk of mortality in the deficient group was 1.9-fold that of the vitamin D sufficiency group (Table 4 ).
Secondary Outcomes
The risk of mortality 90 days following critical care initiation in patients in the 25(OH)D-deficient group was 1.7-fold that of those with vitamin D sufficiency. The multivariable adjusted risk of mortality in the 25(OH)D-deficient group was 1.8-fold that of those with vitamin D sufficiency ( Table 4 ).
The risk of mortality 365 days following critical care initiation in patients in the 25(OH)D deficient group was 1.6-fold that of those with vitamin D sufficiency. The multivariable adjusted risk of mortality in the 25(OH)D-deficient group was 1.7-fold that of those with vitamin D sufficiency ( Table 4 ).
The risk of in-hospital mortality following critical care initiation in patients in the 25(OH)D-deficient group was 1.9fold that of those with vitamin D sufficiency. The multivariable adjusted risk of mortality in the 25(OH)D-deficient group was 1.8-fold that of those with vitamin D sufficiency ( Table 4 ). Figure 1 shows the unadjusted Kaplan-Meier estimates for the time to death, where the difference between the 25(OH)D groups was significant (p ϭ .04 by the log-rank test) and appeared strongest before 45 days. The association between 25(OH)D and 30-day mortality was not materially modified with additional covariate adjustment for the number of organs with failure variable (data not shown).
Effect Modification and Subanalyses
In a subanalysis, we further categorized 25(OH)D as severe deficiency (25(OH)D Յ10 ng/mL), deficiency (25(OH)D 10 -15 ng/mL), insufficiency (25(OH)D 16 -29 ng/ mL), and sufficiency (25(OH)D Ն30 ng/ mL). The risk of mortality 30 days following critical care initiation in patients with 25(OH)D values in the severe deficiency group was 1.9-fold that of those with vitamin D sufficiency (OR 1.87; 95% confidence interval 1.11-3.13; p ϭ .02). 25(OH)D in the cohort remained a significant predictor of risk of mortality following multivariable adjustment. The adjusted risk of 30-day mortality in patients 61 ). There were too few Hispanic cohort patients to provide meaningful analysis regarding effect modification. In a subanalysis of 856 cohort patients with albumin levels present at critical care initiation, the association between vitamin D and mortality was not modified by the presence of albumin Յ2.5 g/dL (p interaction: 30 day ϭ .15, 90 day ϭ .79, 365 day ϭ .70, in-hospital ϭ .71). In a subanalysis of 1,038 cohort patients whose address geocoded and matched the 1990 U.S. Census file, the association between vitamin D and mortality was not modified by the presence or absence of a high (Ͼ20%) neighborhood poverty rate (p interaction: 30 day ϭ .90, 90 day ϭ .91, 365 day ϭ .58, in-hospital ϭ 0.17).
Finally, 25(OH)D was expressed as a continuous variable adjusted for age, gender, race, Deyo-Charlson index, season, patient type, creatinine and sepsis.
The odds for 30-day mortality was 0.98 (95% confidence interval 0.96 -0.99; p ϭ .001). Importantly, this result was multiplicative, so a 1 ng/mL increase in 25(OH)D would have an OR of 0.975 effect on the risk of mortality (a reduction of 2.5%), a 5 ng/mL increase in 25(OH)D would have an OR of 0.975ˆ5 effect on the risk (ϭ 0.88 or a mortality reduction of 12%), and a 10 ng/mL increase would have an OR of 0.975ˆ10 effect (ϭ 0.78 or a mortality reduction of 22%). Effect modification was then determined with 25(OH)D expressed as a continuous variable and albumin Յ2.5 g/dL (the effect modifier) also expressed as a continuous variable. In patients with albumin levels present, the association between vitamin D and mortality was not modified by the presence of albumin Յ2.5 g/dL (p interaction: 30 day ϭ .87, 90 day ϭ .40, 365 day ϭ .65, in-hospital ϭ .73).
DISCUSSION
The goal of the present study was to determine whether 25(OH)D levels at the time of critical care initiation were associated with all-cause mortality. Our 11yr, two-center observational study demonstrates the increased mortality risk related to 25(OH)D deficiency at the time of critical care initiation. 25(OH)D deficiency was a significant predictor of 30-, 90-, and 365-day all-cause mortality, as well as in-hospital mortality, and it remained a significant predictor of mortality following multivariable adjustments for relevant comorbidities.
It is not known if critical illness alters vitamin D levels. Nutritional biomarkers altered by the systemic response to inflammation include albumin, serum iron, vitamins A, C, and E, and other negative acute phase reactants (46 -50) . In our cohort, 85 patients had 25(OH)D measured at critical care initiation and also within a year prior. While a majority of patients had a decrease in 25(OH)D at the time of critical care, one-third saw an increase in 25(OH)D. We postulate that in those whose 25(OH)D increased, supplementation as an outpatient was administered. In those patients whose 25(OH)D decreased, the days to weeks leading up to an intensive care unit admission may have been a factor due to inflammation, immobility, or reduced sun exposure. Alternatively, the critical illness itself may create a vitamin D deficiency state by an unclear mechanism. Importantly, a deficiency state defined by a nutritional bio- marker when not acutely ill often does not increase the susceptibility to illness, but this same marker taken at the time of the critical illness in many instances reflects the criticality of the illness and not the nutritional state.
Patients with sepsis as defined in our study had an increased 30-day mortality following critical care (Table 2) . Sepsis significantly differed between 25(OH)D groups, with the highest in the 25(OH)Ddeficient group (Table 3 ). The observed vitamin D and mortality association is not modified by the presence of sepsis. The interaction tests suggest that the association between 25(OH)D level and mortality is the same in septic patients as in nonseptic patients.
In our study we evaluate neighborhood poverty rate as a proxy of SES to describe social inequities in health (24 -26) as it relates to vitamin D sufficiency. Groups with higher SES have consistently higher intakes of most vitamins relative to lower SES groups (51) . The effect of vitamin D on mortality does not appear to differ by neighborhood poverty rate Ն20%. Outcomes research has shown that race and SES are separate variables that merit investigation (52) . We find that the effect of vitamin D on mortality does not appear to differ in our cohort in nonwhite patients relative to whites or African American patients relative to whites.
The findings of the current study extend and complement our previous report (13) , where we showed that low circulating 25(OH)D levels up to 1 yr before hospital admission were associated with worse outcomes in 2,399 adults following critical care initiation. In comparison to the current study cohort, our previously reported study cohort (13) was predominantly female (57.0% vs. 47.9%), had a higher Deyo-Charlson index (mean 5.6 vs. 3.8), higher 25(OH)D (mean 26.4 vs. 18.2), fewer patients with sepsis (24.1% vs. 27.5%), fewer patients with failure of Ն3 organs (12.0% vs. 26.0%), and lower 30-day mortality (16.7% vs. 17.2%). A significant limitation of our previous report was the investigation of vitamin D levels up to 1 yr before critical care initiation (13) . The current report now investigates vitamin D levels at critical care initiation, and evaluates the effect of race and SES on our observed association between hypovitaminosis D and mortality.
The potential benefit of vitamin D sufficiency appears to occur in the first 45 days following critical care initiation ( Fig. 1 ). This observation, and the high OR for death at 30 days, improves the biological plausibility or at least relevancy of vitamin D sufficiency to the early acute critical illness period. A biologically plausible mechanism for why vitamin D deficiency is associated with mortality after a critical illness may be found in the numerous and diverse functions of vitamin D. Vitamin D inhibits vascular smooth-muscle cell proliferation (53) , protects normal endothelial function (54) , and modulates inflammatory processes (55) (56) . Vitamin D deficiency is found worldwide in young adults, the middle-aged, and the elderly (57) (58) . Severe vitamin D deficiency is reported to be related to susceptibility to upper respiratory tract infections (59) , tuberculosis (60) , and infection in general (61) (62) . A meta-analysis of 18 trials involving 57,311 subjects demonstrated a 7% reduction of all-cause mortality in those supplemented with vitamin D (5) . These observations and others suggest that vitamin D deficiency is likely to play a key role in infection, and cardiac and metabolic dysfunctions in critically ill patients.
1,25 dihydroxyvitamin D3 primarily inhibits adaptive immunity but also has stimulatory effects on innate immunity (63) . Vitamin D deficiency leads to defects in macrophage function related to phagocytosis, chemotaxis, and the production of proinflammatory cytokines (64) . Vitamin D plays a key role linking Toll-like receptor activation and antibacterial responses in innate immunity (65) . Tolllike receptor stimulation of human macrophages induces the conversion of 25(OH)D to active 1,25 dihydroxyvitamin D3, the expression of the vitamin D receptor, and the production of cathelicidin, a downstream target of the vitamin D receptor capable of promoting innate immunity (66 -68) . Cathelicidin is active against a broad spectrum of infectious agents, including Gram-negative and positive bacteria and fungi (69) . Cathelicidin deactivates lipopolysaccharide and also acts as a chemoattractant for T cells, neutrophils, and monocytes (70) . Vitamin D also regulates the expression of ␤-defensin, an antimicrobial peptide with epithelial surface defense function (71) .
Vitamin D promotes the induction of T-regulatory cells (72) (73) (74) , which appear to play a major role in the suppression of immune reactivity in injury (75) (76) and infection (77) . Patients with sepsis have increased numbers of T-regulatory cells in the circulation (78) . Septic patients have decreases in immune responsiveness, predisposing them to nosocomial infections (79) . Immune suppression is also observed with surgical procedures, trauma, burn injury, or hemorrhage, which can predispose patients to nosocomial infections (80 -81) . In such inflammatory or injury states, a decrease in the counter-regulatory process from T-regulatory cells via deficient vitamin D may result in dysfunctional responses to sepsis, inflammation, and injury, which may result in the increased mortality observed in our study.
The present study has limitations. The study was performed in a tertiary referral center and thus is limited in its generalizability. The patient population is entirely composed of patients seen at an academic medical center, which may not be reflective of practices at nonacademic institutions. Selection bias may exist since vitamin D levels may be obtained for a particular reason that is absent in other critically ill patients. A comparison of the total critical care population with the study cohort illustrates the differences between the groups (Table 1 ). Due to database limitations, information on outpatient vitamin D supplementation following critical care is not present. Patients who are treated with vitamin D supplementation as outpatients following critical care may have a long-term survival advantage, which is a limitation of our study. It is not known if critical illness is associated with decreasing 25(OH)D levels. Thus, reverse causation may be present since critical illness may lower 25(OH)D levels. However, in the light of our previous findings where we showed that more remote 25(OH)D levels are also related to mortality following critical care (13) , reverse causation is less likely an explanation of our current findings.
In our study, sepsis and comorbidity are defined based on administrative ICD-9-CM coding. Administrative coding has been studied in particular diseases (82) (83) (84) (85) (86) and comorbidities (87) (88) . ICD-9-CM coding accuracy for the identification of medical conditions is controversial (39) . Algorithms developed to recode ICD-9-CM coded data into a Deyo-Charlson index are well studied, validated, and well suited for use in administrative datasets (89 -90) . Although the ICD-9-CM code 038.x has a high positive predictive value (39) and a high negative predictive value (39) for true cases of sepsis, our reliance only on ICD-9-CM codes to define sepsis is a limitation with regard to the accuracy of our definition of sepsis in our administrative dataset. The lack of effect modification by sepsis on the vitamin D-mortality association may be related to the definition of sepsis by ICD-9-CM codes rather than the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine, American College of Chest Physicians, American Thoracic Society, and Surgical Infection Society International Sepsis Definitions Conference guidelines (91) .
Due to data limitations, we are unable to adjust for physiologic data in our cohort. In the administrative database used in this study, Acute Physiology and Chronic Health Evaluation II scores are not present, since data on temperature, blood pressure, heart rate, respiratory rate, and Glasgow Coma Scale are not recorded. The absence of scoring systems inclusive of physiologic data is a limitation since such scores are strong predictors of mortality in critically ill patients (92) . In the absence of physiologic data, the addition of age and gender data to the Deyo-Charlson comorbidity index is considered an alternative method of risk adjustment (93) . Furthermore, addition of an acute organ dysfunction score (number of failed organs variable) to the risk adjustment did not materially change the association between 25(OH)D and 30-day mortality. Lack of scoring systems inclusive of physiologic data or an acute organ dysfunction score in our study limits the interpretability of the results by intensive care unit clinicians.
Other variables that are not measureable may influence mortality independently of vitamin D, which may have biased estimates. Residual confounding variables may exist despite adjusting for potential confounders contributing to our observed data. Covariate factors that can alter 25(OH)D, such as body mass index, immobilization, lack of sun exposure, and cigarette smoking status, were not available for our study. Finally, due to limitations of the dataset and ICD9 coding accuracy issues, we are unable to determine end-stage renal disease or chronic kidney disease status with confidence for the majority of the cohort (94 -99) . Although stratification of creatinine at critical care initiation cannot distinguish between patients with chronic kidney disease alone, acute kidney injury alone, or acute kidney injury in combination with chronic kidney disease, it does reflect the creatinine at critical care ini-tiation, which we have previously shown is associated with mortality in the "Total Critical Care Population" shown in Table  1 (100) .
The present study has several strengths. All-cause mortality is considered a clinically relevant and unbiased outcome in long-term observational studies (101) (102) . The Social Security Administration Death Master File allows for long-term follow-up of all patients in the study cohort. With a large number of patients and a mortality rate of 16.5%, we can have confidence in the reliability of our mortality estimates. Our use of prior records to define the Deyo-Charlson index increases the prevalence of the conditions of interest and improves risk adjustment (84, 103) . We have previously validated the accuracy of CPT code 99,291 assignment for intensive care unit admission and the accuracy of the Social Security Administration Death Master File for inhospital and out-of-hospital mortality in our administrative database (100) . Finally, we are measuring 25(OH)D at the etiologically relevant time point.
Our data demonstrate that 25(OH)D deficiency at critical care initiation is present and is strongly associated with a significantly increased risk of death, and that this risk is independent of other comorbidities. We believe that our results provide a link between vitamin D at the time of critical care initiation and outcomes in the critically ill. Interpreted together with our prior study of 25(OH)D measured within a year before hospital admission (13) , the current study of 25(OH)D measured at critical care initiation strongly supports the importance of vitamin D sufficiency in critical illness. The administration of high doses of oral 25(OH)D can correct vitamin D deficiency in critically ill patients (104) , but further studies are needed to determine whether vitamin D supplementation can improve morbidity or mortality.
